BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 26 filers reported holding BIOLINERX LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | 0.0% | 2,000 | -12.1% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 2,275 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 2,275 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 2,275 | +13.8% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -77.8% | 2,000 | -77.8% | 0.00% | – |
| Q4 2017 | $9,000 | +50.0% | 9,000 | +80.0% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -89.1% | 5,000 | -87.5% | 0.00% | -100.0% |
| Q3 2016 | $46,000 | +43.8% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $32,000 | -22.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | -10.9% | 40,000 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $46,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |